Skip to content
Screener

Aspire Biopharma Holdings ASBP Q1 2026 Annual earnings

Reported May 15, 2026 · Before market open

Revenue$28.4K
EPS-$20.57

Next report

Date not yet announced

FAQ

When did Aspire Biopharma Holdings report Q1 2026 earnings?
Aspire Biopharma Holdings (ASBP) reported Q1 2026 earnings on May 15, 2026 before market open.
What were Aspire Biopharma Holdings's Q1 2026 revenue and EPS?
Aspire Biopharma Holdings reported revenue of $28.4K and eps of $-20.57 for Q1 2026.
How did Aspire Biopharma Holdings's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 4797.6% from $-0.42.
Where can I find Aspire Biopharma Holdings's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-023069) and the 10-K/A periodic report (0001493152-26-015737) directly on SEC EDGAR. The filing index links above go to sec.gov.